skip to primary navigationskip to content

16.06.16 New model for stem cell self-renewal emphasises reversible states

last modified Jun 21, 2016 04:41 PM
Ben Simons and Philip Greulich show that a model in which stem cells exhibit ‘dynamic heterogeneity’ can robustly explain patterns of self-renewal and differentiation, contributing to our understanding of tissue maintenance.
16.06.16 New model for stem cell self-renewal emphasises reversible states

Illustration of the dynamic heterogeneity model dynamics on a 2D lattice

Dynamic heterogeneity as a strategy of stem cell self-renewal

Greulich P and Simons BD (2016) Proc Natl Acad Sci U S A. DOI 10.1073/pnas.1602779113 [Epub ahead of print] PMID: 27313213


To maintain cycling adult tissue in homeostasis the balance between proliferation and differentiation of stem cells needs to be precisely regulated. To investigate how stem cells achieve perfect self-renewal, emphasis has been placed on models in which stem cells progress sequentially through a one-way proliferative hierarchy. However, investigations of tissue regeneration have revealed a surprising degree of flexibility, with cells normally committed to differentiation able to recover stem cell competence following injury.

Here, we investigate whether the reversible transfer of cells between states poised for proliferation or differentiation may provide a viable mechanism for a heterogeneous stem cell population to maintain homeostasis even under normal physiological conditions. By addressing the clonal dynamics, we show that such models of “dynamic heterogeneity” may be equally capable of describing the results of recent lineage tracing assays involving epithelial tissues. Moreover, together with competition for limited niche access, such models may provide a mechanism to render tissue homeostasis robust. In particular, in 2D epithelial layers, we show that the mechanism of dynamic heterogeneity avoids some pathological dependencies that undermine models based on a hierarchical stem/progenitor organization.


More about the Simons lab.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this

Integrin signaling downregulates filopodia in muscle-tendon attachment

Defining Lineage Potential and Fate Behavior of Precursors during Pancreas Development

DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4

Natural Genetic Variation in a Multigenerational Phenotype in C. elegans

On the origin of the human germline

Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells 

Genome-Scale Oscillations in DNA Methylation during Exit from Pluripotency

Immune Cell Dynamics Unfolded by Single-Cell Technologies

Chromatin Accessibility Impacts Transcriptional Reprogramming in Oocytes

Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta

Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway

SLAM-ITseq: Sequencing cell type-specific transcriptomes without cell sorting

SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements

scmap: projection of single-cell RNA-seq data across data sets

Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48

The developmental origin of brain tumours: a cellular and molecular framework



Link to full list on PubMed